Physician

Michol Stanzione, DO

According to 2025 Medicare claims, Michol Stanzione, DO (NPI: 1396745881) practices internal medicine in the Pinehurst-Southern Pines, NC market, with the plurality of this provider's patient population coming from Moore, NC. This provider's primary affiliated billing organization is PINEHURST MEDICAL CLINIC, INC. (NPI: 1255388369; TIN: 560942980) and primary practice location at 28374-8749. Stanzione is affiliated with the agilon health Mid-Atlantic ACO, Inc. (DBA: Senior Health Connect ACO 5) (ACO ID: D0156), participating under the REACH model.

Stanzione's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,133 traditional Medicare patients, billed 24,119 HCPCS/CPT codes, and received $398,723 in Medicare payments. The top billing code was 82607 (Cyanocobalamin (vitamin b-12) level). Part D data shows 13,855 prescription claims across 774 beneficiaries totaling $1,922,697 in drug costs, led by Ozempic (Semaglutide). DME data shows 123 claims. Open Payments data shows 26 records totaling $557. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $723,562 to $1,922,697. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $16,552 and ending at $17,411.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	691	20,470	$343,835
2016	803	26,999	$372,171
2017	1,436	56,324	$525,013
2018	1,302	45,379	$522,173
2019	1,364	31,620	$481,586
2020	1,261	35,496	$521,690
2021	1,159	37,843	$530,123
2022	1,075	31,922	$484,699
2023	1,240	26,995	$453,735
2024	1,133	24,119	$398,723

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	555	10,251	$723,562
2016	548	10,106	$702,406
2017	769	11,082	$819,573
2018	793	11,898	$931,844
2019	870	11,543	$1,054,337
2020	771	11,840	$1,233,683
2021	813	12,295	$1,456,170
2022	844	12,578	$1,663,770
2023	841	13,356	$2,042,317
2024	774	13,855	$1,922,697

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	86	296	$8,894
2016	63	299	$5,530
2017	86	300	$5,325
2018	81	372	$7,363
2019	92	351	$8,570
2020	54	271	$5,270
2021	33	130	$7,604
2022	30	120	$8,843
2023	15	123	$9,432
2024	13	123	$9,933

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
82607	Cyanocobalamin (vitamin b-12) level	420	901	$15
80053	Blood test, comprehensive group of blood chemicals	421	939	$10
36415	Insertion of needle into vein for collection of blood sample	428	1,094	$9
82248	Bilirubin level, direct	422	934	$5
84100	Phosphate level	422	928	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	153	7,872	$254,496
Eliquis	Apixaban	204	10,698	$204,904
Jardiance	Empagliflozin	186	9,396	$182,887
Trulicity	Dulaglutide	116	4,326	$145,702
Mounjaro	Tirzepatide	78	3,394	$128,193

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	21	$8,732
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	13	33	$650
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	12	$285
E0570	Nebulizer, with compressor	Y	N/R	41	$243
A4259	Lancets, per box of 100	N	N/R	16	$24

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$557	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michol Stanzione, DO?

Tedicare shows public-source Medicare data for Michol Stanzione, DO (NPI 1396745881), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michol Stanzione, DO have ACO affiliation data?

Michol Stanzione, DO is shown with ACO affiliation data for agilon health Mid-Atlantic ACO, Inc. (DBA: Senior Health Connect ACO 5) (REACH, ACO ID D0156).

What billing organization is linked to Michol Stanzione, DO?

Michol Stanzione, DO is linked to PINEHURST MEDICAL CLINIC, INC. (billing NPI 1255388369) in the available physician profile data.

Does Michol Stanzione, DO have Open Payments data?

Michol Stanzione, DO has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.